BDSX financials
Biodesix (BDSX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BDSX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $88.50M | $71.78M | -$27.77M | -$35.27M | -4.67 |
| 2024 | $71.32M | $55.75M | -$34.50M | -$42.93M | -6.62 |
| 2023 | $49.09M | $36.08M | -$41.34M | -$52.15M | -12.70 |
| 2022 | $38.21M | $24.06M | -$50.59M | -$65.45M | -31.09 |
| 2021 | $54.51M | $23.99M | -$40.94M | -$43.16M | -31.54 |
| 2020 | $45.56M | $23.56M | -$22.93M | -$31.35M | -23.61 |
- BDSX revenue was $88.50M in fiscal 2025, net income -$35.27M.
Updated 2026-11-07 11:56 UTC